Figure 1From: Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype Kaplan-Meier survival curves according to subtypes. A Progression-Free Survival (PFS) to AC chemotherapy. B Overall Survival (OS) to AC chemotherapy according to subgroups. C Overall Survival (OS) to AC chemotherapy in patients with TNBCs and non-TNBCsBack to article page